Cross-neutralization and cross-protection among SARS-CoV-2 viruses bearing different variant spikes

被引:0
|
作者
Yang Liu
Jianying Liu
Jing Zou
Birte Kalveram
Rafael R. G. Machado
Ping Ren
Sina Türeli
Derek J. Smith
Scott C. Weaver
Xuping Xie
Pei-Yong Shi
机构
[1] University of Texas Medical Branch,Department of Biochemistry and Molecular Biology
[2] Shenzhen Bay Laboratory,Institute of Infectious Diseases
[3] University of Texas Medical Branch,Department of Microbiology and Immunology
[4] University of Texas Medical Branch,Department of Pathology
[5] University of Cambridge,Center for Pathogen Evolution, Department of Zoology
[6] University of Texas Medical Branch,Sealy Institute for Drug Discovery
[7] University of Texas Medical Branch,Sealy Center for Structural Biology & Molecular Biophysics
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Cross-neutralization and cross-protection among SARS-CoV-2 viruses bearing different variant spikes
    Liu, Yang
    Liu, Jianying
    Zou, Jing
    Kalveram, Birte
    Machado, Rafael R. G.
    Ren, Ping
    Tureli, Sina
    Smith, Derek J.
    Weaver, Scott C.
    Xie, Xuping
    Shi, Pei-Yong
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [2] Cross-protection and cross-neutralization capacity of ancestral and VOC-matched SARS-CoV-2 adenoviral vector-based vaccines
    Vinzon, Sabrina E.
    Lopez, Maria V.
    Cafferata, Eduardo G. A.
    Soto, Ariadna S.
    Berguer, Paula M.
    Vazquez, Luciana
    Nusblat, Leonora
    Pontoriero, Andrea V.
    Belotti, Eduardo M.
    Salvetti, Natalia R.
    Viale, Diego L.
    Vilardo, Ariel E.
    Avaro, Martin M.
    Benedetti, Estefania
    Russo, Mara L.
    Dattero, Maria E.
    Carobene, Mauricio
    Sanchez-Lamas, Maximiliano
    Afonso, Jimena
    Heitrich, Mauro
    Cristofalo, Alejandro E.
    Otero, Lisandro H.
    Baumeister, Elsa G.
    Ortega, Hugo H.
    Edelstein, Alexis
    Podhajcer, Osvaldo L.
    [J]. NPJ VACCINES, 2023, 8 (01)
  • [3] Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection
    Bates, Timothy A.
    McBride, Savannah K.
    Winders, Bradie
    Schoen, Devin
    Trautmann, Lydie
    Curlin, Marcel E.
    Tafesse, Fikadu G.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (02): : 179 - 181
  • [4] Cross-protection and cross-neutralization capacity of ancestral and VOC-matched SARS-CoV-2 adenoviral vector-based vaccines
    Sabrina E. Vinzón
    María V. Lopez
    Eduardo G. A. Cafferata
    Ariadna S. Soto
    Paula M. Berguer
    Luciana Vazquez
    Leonora Nusblat
    Andrea V. Pontoriero
    Eduardo M. Belotti
    Natalia R. Salvetti
    Diego L. Viale
    Ariel E. Vilardo
    Martin M. Avaro
    Estefanía Benedetti
    Mara L. Russo
    María E. Dattero
    Mauricio Carobene
    Maximiliano Sánchez-Lamas
    Jimena Afonso
    Mauro Heitrich
    Alejandro E. Cristófalo
    Lisandro H. Otero
    Elsa G. Baumeister
    Hugo H. Ortega
    Alexis Edelstein
    Osvaldo L. Podhajcer
    [J]. npj Vaccines, 8
  • [5] Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
    Dora Pinto
    Young-Jun Park
    Martina Beltramello
    Alexandra C. Walls
    M. Alejandra Tortorici
    Siro Bianchi
    Stefano Jaconi
    Katja Culap
    Fabrizia Zatta
    Anna De Marco
    Alessia Peter
    Barbara Guarino
    Roberto Spreafico
    Elisabetta Cameroni
    James Brett Case
    Rita E. Chen
    Colin Havenar-Daughton
    Gyorgy Snell
    Amalio Telenti
    Herbert W. Virgin
    Antonio Lanzavecchia
    Michael S. Diamond
    Katja Fink
    David Veesler
    Davide Corti
    [J]. Nature, 2020, 583 : 290 - 295
  • [6] Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2
    Anderson, Danielle E.
    Tan, Chee Wah
    Chia, Wan Ni
    Young, Barnaby E.
    Linster, Martin
    Low, JennyG H.
    Tan, Yee-Joo
    Chen, Mark I-C
    Smith, Gavin J. D.
    Leo, Yee Sin
    Lye, David C.
    Wang, Lin-Fa
    [J]. EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 900 - 902
  • [7] Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages
    Xia, Hongjie
    Yeung, Jason
    Kalveram, Birte
    Bills, Cody J.
    Chen, John Yun-Chung
    Kurhade, Chaitanya
    Zou, Jing
    Widen, Steven G.
    Mann, Brian R.
    Kondor, Rebecca
    Davis, C. Todd
    Zhou, Bin
    Wentworth, David E.
    Xie, Xuping
    Shi, Pei-Yong
    [J]. EMERGING MICROBES & INFECTIONS, 2023, 12 (01)
  • [8] B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
    Scheid, Johannes F.
    Barnes, Christopher O.
    Eraslan, Basak
    Hudak, Andrew
    Keeffe, Jennifer R.
    Cosimi, Lisa A.
    Brown, Eric M.
    Muecksch, Frauke
    Weisblum, Yiska
    Zhang, Shuting
    Delorey, Toni
    Woolley, Ann E.
    Ghantous, Fadi
    Park, Sung-Moo
    Phillips, Devan
    Tusi, Betsabeh
    Huey-Tubman, Kathryn E.
    Cohen, Alexander A.
    Gnanapragasam, Priyanthi N. P.
    Rzasa, Kara
    Hatziioanno, Theodora
    Durney, Michael A.
    Gu, Xiebin
    Tada, Takuya
    Landau, Nathaniel R.
    West, Anthony P., Jr.
    Rozenblatt-Rosen, Orit
    Seaman, Michael S.
    Baden, Lindsey R.
    Graham, Daniel B.
    Deguine, Jacques
    Bieniasz, Paul D.
    Regev, Aviv
    Hung, Deborah
    Bjorkman, Pamela J.
    Xavier, Ramnik J.
    [J]. CELL, 2021, 184 (12) : 3205 - +
  • [9] Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2
    Bruch, Eduardo M.
    Zhu, Shaolong
    Szymkowicz, Lisa
    Blake, Taylor
    Kiss, Tara
    James, D. Andrew
    Rak, Alexey
    Narayan, Kartik
    Balmer, Matthew T.
    Chicz, Roman M.
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01)
  • [10] Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2
    Eduardo M. Bruch
    Shaolong Zhu
    Lisa Szymkowicz
    Taylor Blake
    Tara Kiss
    D. Andrew James
    Alexey Rak
    Kartik Narayan
    Matthew T. Balmer
    Roman M. Chicz
    [J]. Scientific Reports, 14